Real World Data Show Patients with DLBCL Receive Axi-Cel/Tisa-Cel Prior to Treatment Failure – Targeted Oncology
CONTEXT: Report from the European Hematology Association Annual Meeting on a real-world study looking at uses of axicabtagene ciloleucel (Yecarta) and tisagenleucel Kymriah). A review of 93 patients in the Continue Reading